Financhill
Sell
47

CSTL Quote, Financials, Valuation and Earnings

Last price:
$17.36
Seasonality move :
10.13%
Day range:
$18.36 - $19.16
52-week range:
$15.45 - $35.84
Dividend yield:
0%
P/E ratio:
30.24x
P/S ratio:
1.58x
P/B ratio:
1.22x
Volume:
256.8K
Avg. volume:
414.6K
1-year change:
-4.3%
Market cap:
$539.3M
Revenue:
$332.1M
EPS (TTM):
-$0.19

Earnings Data

Next earnings date for CSTL
Aug 04
2025
Most recent earnings per share
-$0.90
Missed by $0.83
(May 5/2025)
Consensus Estimate
-$0.07
(May 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CSTL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $66.9M -- -- -$0.63 --
08/04/2025 Q2 $71.4M -- -- -$0.49 --
05/05/2025 Q1 $80.4M $88M -$0.90 -$0.07 -$0.83
02/27/2025 Q4 $83.9M $86.3M $0.32 $0.04 $0.28
11/04/2024 Q3 $79M $85.8M $0.08 $0.01 $0.07
08/05/2024 Q2 $69.4M $87M $0.31 -$0.25 $0.56
05/02/2024 Q1 $66.2M $73M -$0.09 -$0.31 $0.22
02/28/2024 Q4 $61.2M $66.1M -$0.09 -$0.49 $0.40
11/02/2023 Q3 -- -- -$0.26 -$0.73 $0.47
08/02/2023 Q2 -- -- -$0.70 -$0.91 $0.21
05/03/2023 Q1 -- -- -$1.10 -$0.89 -$0.21
02/28/2023 Q4 -- -- -$0.78 -$0.83 $0.05
11/02/2022 Q3 -- -- -$0.77 -$0.97 $0.20
08/08/2022 Q2 -- -- -$0.06 -$0.80 $0.74
05/09/2022 Q1 -- -- -$0.97 -$0.74 -$0.23
02/28/2022 Q4 -- -- -$0.25 -$0.47 $0.22
11/08/2021 Q3 -- -- -$0.47 -$0.37 -$0.10
08/09/2021 Q2 -- -- -$0.35 -$0.39 $0.04
05/10/2021 Q1 -- -- -$0.17 -$0.19 $0.02
03/08/2021 Q4 -- -- -$0.23 -$0.11 -$0.12
11/09/2020 Q3 -- -- -$0.23 -$0.16 -$0.08
08/10/2020 Q2 -- -- -$0.08 -$0.44 $0.36
05/11/2020 Q1 -- -- $0.03 -$0.05 $0.08
03/10/2020 Q4 -- -- $0.11 -$0.02 $0.13
11/11/2019 Q3 -- -- $0.05 -$0.30 $0.35
09/03/2019 Q2 -- -- -$0.15 -$0.47 $0.32
03/31/2019 Q1 -- -- -$0.22 -- --
12/31/2018 Q4 -- -- $0.27 -- --
09/30/2018 Q3 -- -- -$0.42 -- --
06/30/2018 Q2 -- -- -$0.38 -- --
03/31/2018 Q1 -- -- -$0.42 -- --

Castle Biosciences Earnings Questions

  • How Much did Castle Biosciences Generate in Revenue Last Quarter?

    Castle Biosciences reported $88M worth of top line sales in its most recent quarter.

  • Did Castle Biosciences Beat Earnings Last Quarter?

    Castle Biosciences announced earnings per share of -$0.90 which represents a miss of analyst forecast a -$0.07 per share.

  • Is Castle Biosciences Profitable?

    Castle Biosciences reported $71.6M that represents $2.50 per share over the last quarter.

  • What is the Analyst Consensus for Castle Biosciences EPS Next Year?

    Castle Biosciences's earnings are forecast to decrease from $0.62 per share to $0.40 per share next year representing a decrease of -75.63%.

  • When is Castle Biosciences's Earnings Date?

    Castle Biosciences's next earnings date is August 4, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock